Clinical Trial Detail

NCT ID NCT03885947
Title VPA Expanded UCB Transplantation for Treatment of Patients With Hematological Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Alla Keyzner
Indications

myelodysplastic syndrome

non-Hodgkin lymphoma

acute lymphoblastic leukemia

acute myeloid leukemia

Hodgkin's lymphoma

Therapies

Cyclophosphamide + Fludarabine + Thiotepa

Age Groups: senior adult

No variant requirements are available.